31 104

Cited 0 times in

The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus

 Eun-Jung Park  ;  Hyungjin Kim  ;  Seung Min Jung  ;  Yoon-Kyoung Sung  ;  Han Joo Baek  ;  Jisoo Lee 
 Journal of Rheumatic Diseases, Vol.27(1) : 4-21, 2020-01 
Journal Title
Journal of Rheumatic Diseases
Issue Date
Expert consensus ; bDMARDs ; Inflammatory arthritis ; Rheumatoid arthritis ; Ankylosing spondylitis
Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inflammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid expansion of the bDMARDs market in Korea, reports of serious adverse events related to the agents have also increased, necessitating guidance for the use of bDMARDs. Current work entitled, "Expert Consensus for the Use of bDMARDs Drugs for Inflammatory Arthritis in Korea," is the first to describe the appropriate use of bDMARDs in the management of inflammatory arthritis in Korea, with an aim to provide guidance for the local medical community to improve the quality of clinical care. Twelve consensus statements regarding the use of bDMARDs for the management of rheumatoid arthritis and ankylosing spondylitis were generated. In this review, we provide detailed guidance on bDMARDs use based on expert consensus, including who should prescribe, the role of education, indications for use, and monitoring strategies for safety.
Files in This Item:
T9992020545.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Jung, SeungMin(정승민) ORCID logo https://orcid.org/0000-0003-3465-2181
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.